Company intelligence / Profile preview

China Resources Group

Shenzhen, China
Ownership
Private
Employees
~396400
Development stage
Other
01

Overview

China Resources Group is a large state-owned Chinese conglomerate operating in diverse sectors including healthcare, consumer products, integrated energy, and urban development. Its healthcare arm, China Resources Pharmaceutical Group Limited, is a major player in pharmaceutical manufacturing, distribution, and retail in China.

Modalities
Small MoleculeTraditional Chinese MedicineBiologics
Industry
Pharma
02

Drug pipeline

2 assets

bifidobacterium triple live bacteria

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on China Resources Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on China Resources Group.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call